Nitric oxide signalling and antidepressant action revisited
Open accessThe DOI matches its Crossref record; 204 of the 205 references it cites were found in a registry or an index.
Abstract
Studies about the pathogenesis of mood disorders have consistently shown that multiple factors, including genetic and environmental, play a crucial role on their development and neurobiology. Multiple pathological theories have been proposed, of which several ultimately affects or is a consequence of dysfunction in brain neuroplasticity and homeostatic mechanisms. However, current clinical available pharmacological intervention, which is predominantly monoamine-based, suffers from a partial and lacking response even after weeks of continuous treatment. These issues raise the need for better understanding of aetiologies and brain abnormalities in depression, as well as developing novel treatment strategies. Nitric oxide (NO) is a gaseous unconventional neurotransmitter, which regulates and governs several important physiological functions in the central nervous system, including processes, which can be associated with the development of mood disorders. This review will present general aspects of the NO system in depression, highlighting potential targets that may be utilized and further explored as novel therapeutic targets in the future pharmacotherapy of depression. In particular, the review will link the importance of neuroplasticity mechanisms governed by NO to a possible molecular basis for the antidepressant effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“According to some research, L-arginine may improve sexual function and have a positive impact on the cellular and molecular processes underlying Major Depressive Disorder [24–26].”
From Effect of l-arginine compared to placebo on sexual function in women with major depressive disorder: a randomized controlled trial (2024) · cites this paper as [25]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Oliveira and colleagues found increased nNOS CA1 hippocampal immunoreactivity whereas Bernstein and colleagues found reduced nNOS locus coeruleus immunoreactivity in postmortem samples of depressed patients (123).”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Altogether, there are substantial evidence that P2X7R modulates 5-HT, NA, glutamate, GABA and NO release, which are mechanisms consistently involved in stress and depression [123,129,130].”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [129]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is coherent with evidence that inhibition of NO synthesis induces antidepressant-like effects (for a review, see reference [129]).”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [129]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541
The Epidemiology of Depression Across Cultures
Kessler, R. C., & Bromet, E. J. (2013) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031912-114409 · Cited by 2,657
Garthwaite, J., Charles, S. L., & Chess-Williams, R. (1988) · Nature · doi:10.1038/336385a0 · Cited by 2,549
Dynamics of hippocampal neurogenesis in adult humans
Spalding, K. L., Bergmann, O., Alkass, K., Bernard, S., Salehpour, M., Huttner, H. B., Boström, E., Westerlund, I., Vial, C., Buchholz, B. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.002 · Cited by 1,841
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
Hasin, D. S., Sarvet, A. L., Meyers, J. L., Saha, T. D., Ruan, W. J., Stohl, M., & Grant, B. F. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4602 · Cited by 1,737
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651
Scaling-up treatment of depression and anxiety: a global return on investment analysis
Chisholm, D., Sweeny, K., Sheehan, P., Rasmussen, B., Smit, F., Cuijpers, P., & Saxena, S. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30024-4 · Cited by 1,451
Protein S-nitrosylation: a physiological signal for neuronal nitric oxide
Jaffrey, S. R., Erdjument-Bromage, H., Ferris, C. D., Tempst, P., & Snyder, S. H. (2001) · Nature Cell Biology · doi:10.1038/35055104 · Cited by 1,401
Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders
Autry, A. E., & Monteggia, L. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005108 · Cited by 1,390
The cellular neurobiology of depression
Manji, H. K., Drevets, W. C., & Charney, D. S. (2001) · Nature Medicine · doi:10.1038/87865 · Cited by 1,182
The stress system in the human brain in depression and neurodegeneration
Swaab, D. F., Bao, A.-M., & Lucassen, P. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.003 · Cited by 984
Concepts of neural nitric oxide‐mediated transmission
Garthwaite, J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06285.x · Cited by 807
Kendler, K. S., Thornton, L. M., & Gardner, C. O. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.8.1243 · Cited by 721
Chang, C.-K., Hayes, R. D., Perera, G., Broadbent, M. T. M., Fernandes, A. C., Lee, W. E., Hotopf, M., & Stewart, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019590 · Cited by 714
The physiology and pathophysiology of nitric oxide in the brain
Guix, F. X., Uribesalgo, I., Coma, M., & Muñoz, F. J. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.001 · Cited by 713
Regulation of adult neurogenesis by antidepressant treatment
Duman, R. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00358-x · Cited by 463
PIN: An Associated Protein Inhibitor of Neuronal Nitric Oxide Synthase
Jaffrey, S. R., & Snyder, S. H. (1996) · Science · doi:10.1126/science.274.5288.774 · Cited by 453
BDNF and Hippocampal Synaptic Plasticity
Leal, G., Bramham, C. R., & Duarte, C. B. (2017) · Vitamins and Hormones · doi:10.1016/bs.vh.2016.10.004 · Cited by 425
Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95
Zhou, L., Li, F., Xu, H.-B., Luo, C.-X., Wu, H.-Y., Zhu, M.-M., Lu, W., Ji, X., Zhou, Q.-G., & Zhu, D.-Y. (2010) · Nature Medicine · doi:10.1038/nm.2245 · Cited by 414
Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity
Hölscher, C. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01065-5 · Cited by 408
Sullivan, P. F., de Geus, E. J. C., Willemsen, G., James, M. R., Smit, J. H., Zandbelt, T., Arolt, V, Baune, B. T., Blackwood, D., Cichon, S., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.125 · Cited by 404
Adachi, M., Barrot, M., Autry, A. E., Theobald, D., & Monteggia, L. M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.019 · Cited by 380
Jaffrey, S. R., Snowman, A. M., Eliasson, M. J. L., Cohen, N. A., & Snyder, S. H. (1998) · Neuron · doi:10.1016/s0896-6273(00)80439-0 · Cited by 373
Neuroplasticity and cellular resilience in mood disorders
Manji, H. K., Moore, G. J., Rajkowska, G., & Chen, G. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000811 · Cited by 340
Herken, H., Gurel, A., Selek, S., Armutcu, F., Ozen, M. E., Bulut, M., Kap, O., Yumru, M., Savas, H. A., & Akyol, O. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.10.005 · Cited by 322
Nitric oxide negatively regulates mammalian adult neurogenesis
Packer, M. A., Stasiv, Y., Benraiss, A., Chmielnicki, E., Grinberg, A., Westphal, H., Goldman, S. A., & Enikolopov, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633579100 · Cited by 314
Cheng, A., Wang, S., Cai, J., Rao, M. S., & Mattson, M. P. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00120-9 · Cited by 310
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4950-4 · Cited by 308
Regulation of Adult Neurogenesis by Psychotropic Drugs and Stress
Duman, R. S., Malberg, J., & Nakagawa, S. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29244-2 · Cited by 300
The role of nitric oxide in pre-synaptic plasticity and homeostasis
Hardingham, N., Dachtler, J., & Fox, K. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00190 · Cited by 259
Elevated plasma nitrate levels in depressive states
Suzuki, E., Yagi, G., Nakaki, T., Kanba, S., & Asai, M. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00164-6 · Cited by 255
Nitric oxide stimulates Ca2+-independent synaptic vesicle release
Meffert, M. (1994) · Neuron · doi:10.1016/0896-6273(94)90440-5 · Cited by 255
P2X7 Receptors: Channels, Pores and More
Volonte, C., Apolloni, S., D. Skaper, S., & Burnstock, G. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712803581137 · Cited by 254
Nitric oxide synthase inhibition in migraine
Lassen, L., Ashina, M., Christiansen, I., Ulrich, V, & Olesen, J. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80021-9 · Cited by 252
Neurogenesis in the adult hippocampus
Ehninger, D., & Kempermann, G. (2008) · Cell and Tissue Research · doi:10.1007/s00441-007-0478-3 · Cited by 246
Mortality and life expectancy in persons with severe unipolar depression
Laursen, T. M., Musliner, K. L., Benros, M. E., Vestergaard, M., & Munk-Olsen, T. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.12.067 · Cited by 245
The burden of brain diseases in Europe
Olesen, J., & Leonardi, M. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00682.x · Cited by 242
Nitric oxide synthase inhibitors have antidepressant-like properties in mice
Harkin, A. J., Bruce, K. H., Craft, B., & Paul, I. A. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00191-0 · Cited by 233
Nitric Oxide Modulates Synaptic Vesicle Docking/Fusion Reactions
Meffert, M. K., Calakos, N. C., Scheller, R. H., & Schulman, H. (1996) · Neuron · doi:10.1016/s0896-6273(00)80149-x · Cited by 227
Zhou, Q., Hu, Y., Hua, Y., Hu, M., Luo, C., Han, X., Zhu, X., Wang, B., Xu, J., & Zhu, D. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04914.x · Cited by 225
Bernstein, H.-G., Stanarius, A., Baumann, B., Henning, H., Krell, D., Danos, P., Falkai, P., & Bogerts, B. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00461-2 · Cited by 223
Rivier, C., & Shen, G. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-04-01985.1994 · Cited by 214
Joca, S. R. L., & Guimarães, F. S. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0326-2 · Cited by 204
Self-citationNitric oxide increases dopamine and serotonin release in the medial preoptic area
Lorrain, D. S., & Hull, E. M. (1993) · NeuroReport · doi:10.1097/00001756-199310000-00024 · Cited by 200
(1996) · PubMed · Cited by 194
NO/cGMP-Dependent Modulation of Synaptic Transmission
Feil, R., & Kleppisch, T. (2008) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-74805-2_16 · Cited by 190
Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics
Dulawa, S. C., & Janowsky, D. S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0219-x · Cited by 187
Harvey, D., Yasar, S., Heishman, S., Panlilio, L., Henningfield, J., & Goldberg, S. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1818-6 · Cited by 185
Chanrion, B., Mannoury la Cour, C., Bertaso, F., Lerner-Natoli, M., Freissmuth, M., Millan, M. J., Bockaert, J., & Marin, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610964104 · Cited by 180
Madrigal, J. L. M., Moro, M. A., Lizasoain, I., Lorenzo, P., Castrillo, A., Boscá, L., & Leza, J. C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00108.x · Cited by 180
PSD-95 promotes synaptogenesis and multiinnervated spine formation through nitric oxide signaling
Nikonenko, I., Boda, B., Steen, S., Knott, G., Welker, E., & Muller, D. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200805132 · Cited by 178
Nitric oxide inhibits [3H]dopamine uptake
Pogun, S., Baumann, M. H., & Kuhar, M. J. (1994) · Brain Research · doi:10.1016/0006-8993(94)91818-x · Cited by 176
Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats
Yildiz, F., Erden, B. F., Ulak, G., Utkan, T., & Gacar, N. (2000) · Psychopharmacology · doi:10.1007/s002139900316 · Cited by 174
Costa, A., Trainer, P., Besser, M., & Grossman, A. (1993) · Brain Research · doi:10.1016/0006-8993(93)91739-f · Cited by 174
Volke, V., Wegener, G., Bourin, M., & Vasar, E. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00312-1 · Cited by 170
Self-citationZhao, M., Chen, L., Yang, J., Han, D. H., Fang, D., Qiu, X., Yang, X., Qiao, Z., Ma, J., Wang, L., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.10.024 · Cited by 170
Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo
Wegener, G., Volke, V., & Rosenberg, R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703349 · Cited by 167
Self-citationNitric Oxide Synthase Inhibition: A New Principle in the Treatment of Migraine Attacks
Lassen, L., Ashina, M., Christiansen, I., Ulrich, V, Grover, R., Donaldson, J., & Olesen, J. (1998) · Cephalalgia · doi:10.1046/j.1468-2982.1998.1801027.x · Cited by 166
The calmodulin binding domain of nitric oxide synthase and adenylyl cyclase
Vorherr, T., Knoepfel, L., Hofmann, F., Mollner, S., Pfeuffer, T., & Carafoli, E. (1993) · Biochemistry · doi:10.1021/bi00074a020 · Cited by 165
Harkin, A., Connor, T. J., Burns, M. P., & Kelly, J. P. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.010 · Cited by 164
cGMP Signalling in the Mammalian Brain: Role in Synaptic Plasticity and Behaviour
Kleppisch, T., & Feil, R. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-68964-5_24 · Cited by 161
Harvey, B. H., Stein, D. J., Oosthuizen, F., Brand, L., & Wegener, G. (2003) · Psychopharmacology · doi:10.1007/s00213-004-1836-4 · Cited by 160
Self-citationWegener, G., Volke, V., Harvey, B. H., & Rosenberg, R. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03738-1 · Cited by 160
Self-citationWallerath, T., Gath, I., Aulitzky, W. E., Pollock, J. S., Kleinert, H., & Förstermann, U. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655925 · Cited by 157
Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors
Harkin, A., Connor, T., Walsh, M. P., John, N., & Kelly, J. P. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00030-3 · Cited by 156
Heiberg, I. L., Wegener, G., & Rosenberg, R. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00084-0 · Cited by 143
Self-citationZhou, Q.-G., Zhu, L.-J., Chen, C., Wu, H.-Y., Luo, C.-X., Chang, L., & Zhu, D.-Y. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0004-11.2011 · Cited by 143
Estradiol Regulation of Nitric Oxide Synthase mRNAs in Rat Hypothalamus
Ceccatelli, S., Grandison, L., Scott, R. E. M., Pfaff, D. W., & Kow, L.-M. (1996) · Neuroendocrinology · doi:10.1159/000127139 · Cited by 142
Tanda, K., Nishi, A., Matsuo, N., Nakanishi, K., Yamasaki, N., Sugimoto, T., Toyama, K., Takao, K., & Miyakawa, T. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-19 · Cited by 134
Dhir, A., & Kulkarni, S. K. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.028 · Cited by 133
Nitric oxide induces calcium‐dependent release of [3H]dopamine release from striatal slices
Lónárt, G., Cassels, K. L., & Johnson, K. M. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490350210 · Cited by 132
Neuronal nitric oxide synthase knock-out mice show impaired cognitive performance
Weitzdoerfer, R., Hoeger, H., Engidawork, E., Engelmann, M., Singewald, N., Lübec, G., & Lubec, B. (2004) · Nitric Oxide · doi:10.1016/j.niox.2004.03.007 · Cited by 130
The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis
Zaragoza, C., Ocampo, C., Saura, M., Leppo, M., Wei, X.-Q., Quick, R., Moncada, S., Liew, F. Y., & Lowenstein, C. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2469 · Cited by 122
Segovia, G., Del Arco, A., & Mora, F. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041476.x · Cited by 121
Nitric oxide modulates the release of serotonin in the rat hypothalamus
Kaehler, S. T., Singewald, N., Sinner, C., & Philippu, A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01599-1 · Cited by 119
Segovia, G., Porras, A., & Mora, F. (1994) · Neuroreport · doi:10.1097/00001756-199410000-00024 · Cited by 117
SPIACCIJR, A., KANAMARU, F., Guimarães, F. S., & de Oliveira, R. M. W. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.08.008 · Cited by 116
Mancuso, C., Navarra, P., & Preziosi, P. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06606.x · Cited by 116
Lonart, G., & Johnson, K. M. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062108.x · Cited by 115
Petzer, A., Harvey, B. H., Wegener, G., & Petzer, J. P. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.12.005 · Cited by 114
Self-citationNADPH-diaphorase activity in the hypothalamic magnocellular neurosecretory nuclei of the rat
Arévalo, R., Sánchez, F., Alonso, J. R., Carreterco, J., Vázquezt, R., & Aijón, J. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90109-b · Cited by 114
Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders
Oliveira, R. M. W., Guimarães, F. S., & Deakin, J. F. W. (2008) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2008000400012 · Cited by 112
Increased plasma nitric oxide level associated with suicide attempt in depressive patients
Kim, Y., Paik, J., Lee, S.-W., Yoon, D., Han, C., & Lee, B.-H. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.04.008 · Cited by 109
Canossa, M., Giordano, E., Cappello, S., Guarnieri, C., & Ferri, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042504299 · Cited by 106
Xing, G., Chavko, M., Zhang, L.-X., Yang, S., & Post, R. M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00388-7 · Cited by 105
Nitric oxide and hippocampal synaptic plasticity
Zorumski, C. F., & Izumi, Y. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90484-e · Cited by 105
Tang, J., Yu, W., Chen, S., Gao, Z., & Xiao, B. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2504-0 · Cited by 104
Nitric oxide inhibits 3H‐glutamate transport in synaptosomes
Pogun, S., Dawson, V., & Kuhar, M. J. (1994) · Synapse · doi:10.1002/syn.890180104 · Cited by 102
Nitric oxide transforms serotonin into an inactive form and this affects neuromodulation
Fossier, P., Blanchard, B., Ducrocq, C., Leprince, C., Tauc, L., & Baux, G. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00165-7 · Cited by 102
L-arginine induces dopamine release from the striatum in vivo
Strasser, A., McCarron, R. M., Ishii, H., Stanimirovic, D., & Spatz, M. (1994) · NeuroReport · doi:10.1097/00001756-199411000-00023 · Cited by 102
Behavioral stress alters corticolimbic microglia in a sex- and brain region-specific manner
Bollinger, J. L., Collins, K. E., Patel, R., & Wellman, C. L. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187631 · Cited by 100
Distribution of soluble guanylyl cyclase in the rat brain
Ding, J., Burette, A., Nedvetsky, P. I., Schmidt, H. H. H. W., & Weinberg, R. J. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20054 · Cited by 97
Bhat, G., Mahesh, V. B., Aguan, K., & Brann, D. W. (1996) · Neuroendocrinology · doi:10.1159/000127104 · Cited by 97
Ghasemi, M., Sadeghipour, H., Mosleh, A., Sadeghipour, H. R., Mani, A. R., & Dehpour, A. R. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.07.011 · Cited by 96
Naylor, G. J., Martin, B., Hopwood, S. E., & Watson, Y. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90265-9 · Cited by 96
Antidepressant action of ketamine via mTOR is mediated by inhibition of nitrergic Rheb degradation
Harraz, M. M., Tyagi, R., Cortés, P., & Snyder, S. H. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.211 · Cited by 95
Papanastassiou, V., Rowe, J. G., Scott, R., Silburn, P. A., DAVIES, L. E., & Aziz, T. Z. (1998) · Journal of Clinical Neuroscience · doi:10.1016/s0967-5868(98)90197-7 · Cited by 95
Nitric Oxide Synthase Inhibitors as Antidepressants
Wegener, G., & Volke, V. (2010) · Pharmaceuticals · doi:10.3390/ph3010273 · Cited by 94
Self-citationZhu, X., Hua, Y., Jiang, J., Zhou, Q., Luo, C., Han, X., Lu, Y. M., & Zhu, D. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.04.032 · Cited by 91
Nitric Oxide-Directed Synaptic Remodeling in the Adult Mammal CNS
Sunico, C. R., Portillo, F., González-Forero, D., & Moreno-López, B. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4600-04.2005 · Cited by 90
Inhibition of iNOS induces antidepressant-like effects in mice: Pharmacological and genetic evidence
Montezuma, K., Biojone, C., Lisboa, S. F. D. S., Cunha, F. Q., Guimarães, F. S., & Joca, S. R. L. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.09.004 · Cited by 90
Self-citationNitric oxide and long-term synaptic depression in the rat hippocampus.
Izumi, Y., & Zorumski, C. F. (1993) · PubMed · Cited by 90
Increased Plasma Nitric Oxide Metabolites in Suicide Attempters
Lee, B.-H., Lee, S.-W., Yoon, D., Lee, H.-J., Yang, J.-C., Shim, S.-H., Kim, D.-H., Ryu, S.-H., Han, C., & Kim, Y.-K. (2006) · Neuropsychobiology · doi:10.1159/000092542 · Cited by 88
Srivastava, N., Barthwal, M. K., Dalal, P., Agarwal, A., Nag, D., Seth, P. K., Srimal, R. C., & Dikshit, M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00421-9 · Cited by 85
Jessé, C. R., Bortolatto, C. F., Savegnago, L., da Rocha, J. B. T., & Nogueira, C. W. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.08.010 · Cited by 85
Low nNOS protein in the locus coeruleus in major depression
Karolewicz, B., Szebeni, K., Stockmeier, C. A., Konick, L., Overholser, J. C., Jurjus, G., Roth, B. L., & Ordway, G. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02792.x · Cited by 84
Matarredona, E. R., Murillo‐Carretero, M., Moreno‐López, B., & Estrada, C. (2003) · Brain Research · doi:10.1016/j.brainres.2003.10.010 · Cited by 82
Mizoguchi, Y., Kato, T. A., Seki, Y., Ohgidani, M., Sagata, N., Horikawa, H., Yamauchi, Y., Sato-Kasai, M., Hayakawa, K., Inoue, R., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.555334 · Cited by 81
Mutlu, O., Ulak, G., Laugeray, A., & Belzung, C. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.10.013 · Cited by 77
A controlled trial of methylene blue in severe depressive illness
Naylor, G. J., Smith, A. H. W., & Connelly, P. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90194-6 · Cited by 75
Small-Molecule Inhibitors at the PSD-95/nNOS Interface have Antidepressant-Like Properties in Mice
Doucet, M. V., Levine, H., Dev, K. K., & Harkin, A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.57 · Cited by 74
Krass, M., Wegener, G., Vasar, E., & Volke, V. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.027 · Cited by 73
Self-citationThe current development of CNS drug research
Wegener, G., & Rujescu, D. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000345 · Cited by 73
Self-citationWegener, G., Harvey, B. H., Bonefeld, B., Müller, H. K., Volke, V., Overstreet, D. H., & Elfving, B. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990241 · Cited by 72
Self-citationRabinovich, D., Yaniv, S. P., Alyagor, I., & Schuldiner, O. (2016) · Cell · doi:10.1016/j.cell.2015.11.047 · Cited by 72
Methylene blue treatment for residual symptoms of bipolar disorder: Randomised crossover study
Alda, M., McKinnon, M. C., Blagdon, R. A., Garnham, J. S., MacLellan, S., O’Donovan, C., Hájek, T., Nair, C., Dursun, S. M., & MacQUEEN, G. M. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.173930 · Cited by 72
Bugajski, J., Gądek-Michalska, A., & Bugajski, A. J. (2004) · PubMed · Cited by 68
Lisboa, S. F. D. S., Gomes, F. V., Silva, A. L., Uliana, D. L., Camargo, L. H. A., Guimarães, F. S., Cunha, F. Q., Joca, S. R. L., & Resstel, L. B. M. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv005 · Cited by 68
Self-citationXiong, H., Yamada, K., Han, D., Nabeshima, T., Enikolopov, G., Carnahan, J., & Nawa, H. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00567.x · Cited by 67
Luo, C.-X., Jin, X., Cao, C.-C., Zhu, M.-M., Wang, B., Chang, L., Zhou, Q.-G., Wu, H.-Y., & Zhu, D.-Y. (2010) · Stem Cells · doi:10.1002/stem.522 · Cited by 67
Roles of Nitric Oxide Synthase Isoforms in Neurogenesis
Chong, C., Ai, N., Ke, M., Tan, Y., Huang, Z., Li, Y., Lu, J., Ge, W., & Su, H. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0513-7 · Cited by 67
Kuhn, D. M., & Arthur, R. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-19-07245.1997 · Cited by 66
Stanford, S. C., Stanford, B. J., & Gillman, P. K. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109105450 · Cited by 66
Pereira, V. S., Casarotto, P. C., Hiroaki-Sato, V. A., Sartim, A. G., Guimarães, F. S., & Joca, S. R. L. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.01.008 · Cited by 66
Self-citationMethylene blue inhibits hippocampal nitric oxide synthase activity in vivo
Volke, V., Wegener, G., Vasar, E., & Rosenberg, R. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01253-6 · Cited by 65
Self-citationTsuchiya, T., Kishimoto, J., Koyama, J., & Ozawa, T. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00942-6 · Cited by 64
Inducible Nitric Oxide Synthase Protection Against Coxsackievirus Pancreatitis
Zaragoza, C., Ocampo, C. J., Saura, M., Bao, C., Leppo, M., Lafond-Walker, A., Thiemann, D. R., Hruban, R., & Lowenstein, C. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5497 · Cited by 64
Gałecki, P., Maes, M. H. J., Florkowski, A., Lewiñski, A., Gałecka, E., Bieńkiewicz, M., & Szemraj, J. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.09.005 · Cited by 63
Nitric oxide theory of migraine.
Thomsen, L. L., & Olesen, J. (1998) · PubMed · Cited by 63
Inactivation of Brain Tryptophan Hydroxylase by Nitric Oxide
Kuhn, D. M., & Arthur, R. E. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67031072.x · Cited by 63
Pinnock, S. B., & Herbert, J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06250.x · Cited by 62
Interplay Between Nitric Oxide and Brain-Derived Neurotrophic Factor in Neuronal Plasticity
Biojone, C., Casarotto, P., Joca, S., & Castren, E. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150909113727 · Cited by 62
Self-citationPhysiologic role for “inducible” nitric oxide synthase: A new form of astrocytic–neuronal interface
Amitai, Y. (2010) · Glia · doi:10.1002/glia.21057 · Cited by 62
Pleiotropic contributions of nitric oxide to aggressive behavior
Nelson, R. J., Trainor, B. C., Chiavegatto, S., & Demas, G. E. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.02.002 · Cited by 62
Involvement of NO–cGMP pathway in anti-anxiety effect of aminoguanidine in stressed mice
Gilhotra, N., & Dhingra, D. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.08.012 · Cited by 61
Thomsen, L. (1997) · Cephalalgia · doi:10.1046/j.1468-2982.1997.1708873.x · Cited by 61
Regulation of Neurotransmitter Reuptake by Nitric Oxide
PÖÜN, Ş., & Kuhar, M. J. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21816.x · Cited by 61
Silva, M., de Aguiar, D. C., Diniz, C. R. A. F., Guimarães, F. S., & Joca, S. R. L. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9775-1 · Cited by 57
Self-citationNylén, A., Skagerberg, G., Alm, P., LARSSON, B. S., Holmqvist, B. I., & Andersson, K.-E. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02539-2 · Cited by 56
Yu, Y. W.-Y., Chen, T.-J., Wang, Y.-C., Liou, Y.-J., Hong, C.-J., & Tsai, S.-J. (2003) · Neuropsychobiology · doi:10.1159/000070582 · Cited by 54
Lasserre, A. M., Martí-Soler, H., Strippoli, M. F., Vaucher, J., Glaus, J., Vandeleur, C. L., Castelao, E., Marques-Vidal, P. M., Waeber, G., Vollenweider, P., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.09.010 · Cited by 52
Raiteri, M., Maura, G., & Barzizza, A. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24728-0 · Cited by 52
Methylene blue and its analogues as antidepressant compounds
Delport, A., Harvey, B. H., Petzer, A., & Petzer, J. P. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0081-6 · Cited by 51
Nitric oxide is involved in the regulation of marble-burying behavior
Krass, M., Rünkorg, K., Wegener, G., & Volke, V. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.06.002 · Cited by 50
Self-citationNitric oxide mediates local activity-dependent excitatory synapse development
Nikonenko, I., Nikonenko, A. G., Méndez, P., Michurina, T. V., Enikolopov, G., & Müller, D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311927110 · Cited by 49
Buskila, Y., Abu‐Ghanem, Y., Levi, Y., Moran, A., Grauer, E., & Amitai, Y. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000843 · Cited by 48
Harvey, B. H., Bothma, T., Nel, A., Wegener, G., & Stein, D. J. (2005) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.695 · Cited by 47
Self-citationRomero‐Grimaldi, C., Moreno‐López, B., & Estrada, C. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21556 · Cited by 47
PSD-95-nNOS Coupling Regulates Contextual Fear Extinction in the Dorsal CA3
Cai, C.-Y., Chen, C., Zhou, Y., Han, Z., Qin, C., Cao, B., Tao, Y., Bian, X.-L., Lin, Y., Chang, L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30899-4 · Cited by 47
BERNSTEIN, H. ‐., HEINEMANN, A., KRELL, D., MAWRIN, C., BIELAU, H., DANOS, P., DIEKMANN, S., KEILHOFF, G., BOGERTS, B., & BAUMANN, B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04613.x · Cited by 46
Yazir, Y., Utkan, T., & Aricioglu, F. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2012.00877.x · Cited by 45
Liebenberg, N., Joca, S., & Wegener, G. (2015) · Acta Neuropsychiatrica · doi:10.1017/neu.2014.39 · Cited by 45
Self-citationStress-induced increase in extracellular sucrose space in rats is mediated by nitric oxide
Madrigal, J. L. M., Moro, M. Á., Lizasoaín, I., Lorenzo, P. L., & Leza, J. C. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02467-8 · Cited by 44
Li, Y.-F., Zhang, Y.-Z., Liu, Y.-Q., Wang, H.-L., Cao, J.-B., Guan, T.-T., & Luo, Z.-P. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106059692 · Cited by 44
Role of Gaseous Neurotransmitters in the Hypothalamic‐Pituitary‐Adrenal Axis
Rivier, C. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05829.x · Cited by 43
Pereira, V. S., Suavinha, A. C. D. R., Wegener, G., & Joca, S. R. L. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3853-2 · Cited by 39
Self-citationZhang, G.-F., Wang, N., Shi, J., Shixia, X., Li, X., Ji, M., Zuo, Z., Zhou, Z., & Yang, J. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.05.010 · Cited by 38
Seo, D. O., & Rivier, C. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2001.00690.x · Cited by 36
Borda, T., Genaro, A. M., Sterin‐Borda, L., & Cremaschi, G. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050048 · Cited by 36
Do ATP and NO interact in the CNS?
Florenzano, F., Viscomi, M. T., Amadio, S., D’Ambrosi, N., Volonté, C., & Molinari, M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.10.004 · Cited by 36
Mitochondrial dysfunction associated with nitric oxide pathways in glutamate neurotoxicity
Manucha, W. A. (2016) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2016.04.002 · Cited by 35
Brand, S. J., & Harvey, B. H. (2016) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.44 · Cited by 32
Kolarow, R., Kuhlmann, C. R. W., Munsch, T., Zehendner, C. M., Brigadski, T., Luhmann, H. J., & Leßmann, V. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00323 · Cited by 31
Nitric oxide involvement in depression during interferon-alpha therapy
Suzuki, E., Yoshida, Y., Shibuya, A., & Miyaoka, H. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003766 · Cited by 31
Methylene blue is a potent monoamine oxidase inhibitor
Gillman, P. K., Ng, B., Cameron, A. J. D., & Liang, R. W. Y. (2008) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03017212 · Cited by 31
Marcoli, M., Maura, G., Tortarolo, M., & Raiteri, M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010427.x · Cited by 31
Naylor, G. J., Smith, A. H. W., & Connelly, P. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90229-6 · Cited by 31
Lescai, F., Als, T. D., McQuillin, A., Nyegaard, M., Andorsdóttir, G., Biskopstø, M., Hedemand, A., Fiorentino, A., O’Brien, N. L., Jarram, A., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.3 · Cited by 31
Islam, A. T. M. S., Kuraoka, A., & Kawabuchi, M. (2003) · Anatomical Science International · doi:10.1046/j.0022-7722.2003.00045.x · Cited by 30
Antidepressant-like effect of agmatine is not mediated by serotonin
Krass, M., Wegener, G., Vasar, E., & Volke, V. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.11.013 · Cited by 30
Self-citationHippocampal nNOS inhibition induces an antidepressant-like effect: involvement of 5HT1A receptors
Sato, V., Sales, A. J., Biojone, C., & Joca, S. R. L. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000035 · Cited by 29
Self-citationRIVIER, C. L. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03139.x · Cited by 28
Stanquini, L. A., Biojone, C., Guimarães, F. S., & Joca, S. R. L. (2017) · Acta Neuropsychiatrica · doi:10.1017/neu.2017.28 · Cited by 28
Self-citationEraldemir, F. C., Özsoy, Ö. D., Bek, S. G., Kır, H. M., & Dervişoğlu, E. (2015) · Renal Failure · doi:10.3109/0886022x.2015.1011551 · Cited by 26
Bauer, M. B., Murphy, S. P., & Gebhart, G. F. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90370-0 · Cited by 26
Ehringer, H., Hornykiewicz, O., & Lechner, K. (1961) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf02438625 · Cited by 25
Delport, A., Harvey, B. H., Petzer, A., & Petzer, J. P. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00042 · Cited by 25
Okumura, T., Kishi, T., Okochi, T., Ikeda, M., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Tsunoka, T., Inada, T., et al. (2010) · Neuropsychobiology · doi:10.1159/000265130 · Cited by 24
Diniz, C. R. A. F., Casarotto, P. C., & Joca, S. R. L. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.03.037 · Cited by 23
Self-citationCentral nitric oxide regulation of the hypothalamic–pituitary–adrenocortical axis in adult male rats
Givalois, L., Li, S., & Pelletier, G. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00218-8 · Cited by 22
Abu‐Ghanem, Y., Cohen, H., Buskila, Y., Grauer, E., & Amitai, Y. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.043 · Cited by 22
Joca, S. R. L., Guimarães, F. S., & Del-Bel, E. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.05.026 · Cited by 21
Self-citationBrand, S. J., & Harvey, B. H. (2016) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.50 · Cited by 21
Badenhorst, N. J., Brand, L., Harvey, B. H., Ellis, S. M., & Brink, C. B. (2016) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.53 · Cited by 21
Park, S., Kang, M., & Han, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0110-1 · Cited by 20
Tillmann, S., Pereira, V. S., Liebenberg, N., Christensen, A. K., & Wegener, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182698 · Cited by 20
Self-citationFassini, A., Antero, L. S., Corrêa, F. M. D. A., Joca, S. R. L., & Resstel, L. B. M. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23537 · Cited by 18
Self-citationCost of disorders of the brain in Denmark
Olesen, J., Sobscki, P., Truelsen, T. C., Sestoft, D., & Jönsson, B. (2008) · Nordic Journal of Psychiatry · doi:10.1080/08039480801979792 · Cited by 18
Doucet, M. V., O’Toole, E., Connor, T., & Harkin, A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.004 · Cited by 17
Nitric oxide activation of TrkB through peroxynitrite
Yuen, E., Gunther, E. C., & Bothwell, M. A. (2000) · Neuroreport · doi:10.1097/00001756-200011090-00038 · Cited by 16
Okada, S., Murakami, Y., & Yokotani, K. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02540-4 · Cited by 16
Gądek-Michalska, A., Tadeusz, J., Rachwalska, P., & Bugajski, J. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.09.003 · Cited by 16
Pereira, V. S., Elfving, B., Joca, S. R. L., & Wegener, G. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.09.029 · Cited by 16
Self-citation
Research works printed but not linked: 3
- 59. Gray WP, Cheung A (2014) Chapter four-nitric oxide regulation of adult neurogenesis. In: Litwack G (ed) Vitamins & hormones, vol 96. Academic Press, pp 59-77
- 82. Joca S, Biojone C, Casarotto P, Montezuma K, Cunha F, Guimaraes F (2012) BDNF-TrkB signaling is involved in the antidepressant-like e ff e c t i n d u c e d b y g e n e t i c d e l e t i o n o f i N O S . I n t J Neuropsychopharmacol 15:44-45
- 150. Rivier C, Shen GH (1994b) In the rat, endogenous nitric oxide modulates the response of the hypothalamic-pituitary-adrenal axis to interleu- kin-1β, vasopressin, and oxytocin. J Neurosci 14:1985-1993 · DOI · Paper page
Cited by
Hassamal, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1130989 · Cited by 578
“Oliveira and colleagues found increased nNOS CA1 hippocampal immunoreactivity whereas Bernstein and colleagues found reduced nNOS locus coeruleus immunoreactivity in postmortem samples of depressed patients (123).”
BackgroundMitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation
Yang, L., Youngblood, H. A., Wu, C., & Zhang, Q. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00197-z · Cited by 154
P2X7 Receptor Signaling in Stress and Depression
Ribeiro, D. E., Roncalho, A. L., Glaser, T., Ulrich, H., Wegener, G., & Joca, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112778 · Cited by 129
“This is coherent with evidence that inhibition of NO synthesis induces antidepressant-like effects (for a review, see reference [129]).”
BackgroundSelf-citationvan Vuren, E. J., Steyn, S. F., Brink, C. B., Möller, M., Viljoen, F. P., & Harvey, B. H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111200 · Cited by 111
“Importantly, both nNOS- and iNOS-derived NO levels were altered in the limbic brain regions of stressed animals [140].”
Nitrergic Enteric Neurons in Health and Disease—Focus on Animal Models
Bódi, N., Szalai, Z., & Bagyánszki, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20082003 · Cited by 74
“Although more than 20 years have passed since the biological properties of NO were discovered [73,74], many questions remain unanswered concerning the role of NO in neurons both in the gut and the brain [75].”
Background
Metadata
- Authors
- Joca, S. R. L., Sartim, A. G., Roncalho, A. L., Diniz, C. F. A., & Wegener, G.
- Affiliations
- Universidade de São Paulo (BR)
- Aarhus University (DK)
- Corresponding author
- Wegener, Gregers
- Venue
- Cell and Tissue Research
- Published
- 2019-01-16
- Volume
- 377
- Issue
- 1
- Pages
- 45-58
- ISSN
- 0302-766X (ISSN-L)
- 1432-0878
- OpenAlex
- W2909163875
- Semantic Scholar
- 4051d1c2e0abafa68bc1a34962a89f4fa358f3f8
- Cited by
- 63
- References
- 205
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 10 · 2023: 9 · 2022: 10 · 2021: 8 · 2020: 10 · 2019: 6
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Cell and Tissue Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Aarhus Universitets Forskningsfond (eMOOD)
- Sundhed og Sygdom, Det Frie Forskningsr?d (8020-00310B)
- H2020 Marie Sk?odowska-Curie Actions (ExEDE)
- Instituto Nacional de Ci?ncia e Tecnologia da Criosfera (306648/2014-8, Post doc Fellowship, PhD Fellowship)
- Aarhus Institute of Advanced Studies, Aarhus Universitet (AIAS Cofund Senior Fellowship)
- Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo (Research Fellowship)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- nitric oxide, depression, antidepressant action, mood disorders, neuroplasticity, novel therapeutic targets, no-signaling, antidepressant resistance
- MeSH terms
- Animals, Antidepressive Agents, Brain, Humans, Neuronal Plasticity, Nitric Oxide, Signal Transduction, Neurotransmitter Agents, Brain-Derived Neurotrophic Factor, Mood Disorders, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.